Takashi Inozume

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Signaling Pathway

Regulatory T Cells

Basal Cell Carcinoma

Top Venues

The Journal of dermatology

Experimental dermatology

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yuto Naoi, Takao Morinaga, Joji Nagasaki, Ryo Ariyasu, Youki Ueda, Kazuo Yamashita, Wenhao Zhou, Shusuke Kawashima, Katsushige Kawase, Akiko Honobe-Tabuchi, Takehiro Ohnuma, Tatsuyoshi Kawamura, Yoshiyasu Umeda, Yu Kawahara, Yasuhiro Nakamura, Yukiko Kiniwa, Osamu Yamasaki, Satoshi Fukushima, Masahito Kawazu, Yutaka Suzuki, Hiroyoshi Nishikawa, Toyoyuki Hanazawa, Mizuo Ando, Takashi Inozume, Yosuke Togashi
CD106 in tumor-specific exhausted CD8+ T cells mediates immunosuppression by inhibiting TCR signaling. Cancer research (2024)
Shigeru Koizumi, Reiichi Doi, Urara Aitake, Xiaofeng Lei, Teruaki Izumi, Tatsuhiko Mori, Naoko Shojiguchi, Tomonori Kawasaki, Takashi Inozume, Akiko Kishi
Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens. The Journal of dermatology 51 (6) (2024)
Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, Takashi Inozume, Joji Nagasaki, Youki Ueda, Ken Suzawa, Toshihide Ueno, Hideki Ikeda, Katsushige Kawase, Yuka Saeki, Shusuke Kawashima, Kazuo Yamashita, Yu Kawahara, Yasuhiro Nakamura, Akiko Honobe-Tabuchi, Hiroko Watanabe, Hiromichi Dansako, Tatsuyoshi Kawamura, Yutaka Suzuki, Hiroaki Honda, Hiroyuki Mano, Shinichi Toyooka, Masahito Kawazu, Yosuke Togashi
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity. Proceedings of the National Academy of Sciences of the United States of America 121 (35) (2024)
Shigeru Koizumi, Reiichi Doi, Urara Aitake, Xiaofeng Lei, Teruaki Izumi, Tatsuhiko Mori, Naoko Shojiguchi, Tomonori Kawasaki, Takashi Inozume, Akiko Kishi
Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens. The Journal of dermatology (2024)
Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, Takashi Inozume, Joji Nagasaki, Youki Ueda, Ken Suzawa, Toshihide Ueno, Hideki Ikeda, Katsushige Kawase, Yuka Saeki, Shusuke Kawashima, Kazuo Yamashita, Yu Kawahara, Yasuhiro Nakamura, Akiko Honobe-Tabuchi, Hiroko Watanabe, Hiromichi Dansako, Tatsuyoshi Kawamura, Yutaka Suzuki, Hiroaki Honda, Hiroyuki Mano, Shinichi Toyooka, Masahito Kawazu, Yosuke Togashi
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity. Proceedings of the National Academy of Sciences of the United States of America 121 (35) (2024)
Yuto Naoi, Takao Morinaga, Joji Nagasaki, Ryo Ariyasu, Youki Ueda, Kazuo Yamashita, Wenhao Zhou, Shusuke Kawashima, Katsushige Kawase, Akiko Honobe-Tabuchi, Takehiro Ohnuma, Tatsuyoshi Kawamura, Yoshiyasu Umeda, Yu Kawahara, Yasuhiro Nakamura, Yukiko Kiniwa, Osamu Yamasaki, Satoshi Fukushima, Masahito Kawazu, Yutaka Suzuki, Hiroyoshi Nishikawa, Toyoyuki Hanazawa, Mizuo Ando, Takashi Inozume, Yosuke Togashi
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling. Cancer research 84 (13) (2024)
Kenji Yokota, Tatsuya Takenouchi, Yasuhiro Fujisawa, Satoshi Fukushima, Hiroshi Uchi, Takashi Inozume, Yoshio Kiyohara, Hisashi Uhara, Kazuhiko Nakagawa, Hiroshi Furukawa, Shirong Han, Masaru Watanabe, Kazuo Noguchi, Naoya Yamazaki
Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma. The Journal of dermatology (2024)
Takashi Inozume, Satoshi Fukushima, Tomoo Fukuda, Kazutoshi Harada
Does dermatophytosis of the feet cause acral melanoma? The Journal of dermatology (2024)
Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, Takashi Inozume, Joji Nagasaki, Youki Ueda, Ken Suzawa, Toshihide Ueno, Hideki Ikeda, Katsushige Kawase, Yuka Saeki, Shusuke Kawashima, Kazuo Yamashita, Yu Kawahara, Yasuhiro Nakamura, Akiko Honobe-Tabuchi, Hiroko Watanabe, Hiromichi Dansako, Tatsuyoshi Kawamura, Yutaka Suzuki, Hiroaki Honda, Hiroyuki Mano, Shinichi Toyooka, Masahito Kawazu, Yosuke Togashi
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity. Proceedings of the National Academy of Sciences of the United States of America 121 (35) (2024)
Kenji Yokota, Tatsuya Takenouchi, Yasuhiro Fujisawa, Satoshi Fukushima, Hiroshi Uchi, Takashi Inozume, Yoshio Kiyohara, Hisashi Uhara, Kazuhiko Nakagawa, Hiroshi Furukawa, Shirong Han, Masaru Watanabe, Kazuo Noguchi, Naoya Yamazaki
Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma. The Journal of dermatology 51 (5) (2024)
Takashi Inozume, Satoshi Fukushima
Clues for developing next-generation cancer immunotherapy. Experimental dermatology (2023)
Takashi Inozume, Satoshi Fukushima
Clues for developing next-generation cancer immunotherapy. Experimental dermatology 32 (3) (2023)
Takashi Inozume, Satoshi Fukushima
Clues for developing next-generation cancer immunotherapy. Experimental dermatology 32 (3) (2023)
Shigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
Current surgical management for melanoma. The Journal of dermatology (2023)
Katsushige Kawase, Shusuke Kawashima, Joji Nagasaki, Takashi Inozume, Etsuko Tanji, Masahito Kawazu, Toyoyuki Hanazawa, Yosuke Togashi
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects. Cancer immunology research (2023)
Takashi Inozume, Satoshi Fukushima
Clues for developing next-generation cancer immunotherapy. Experimental dermatology 32 (3) (2023)
Shigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
Current surgical management for melanoma. The Journal of dermatology 51 (3) (2023)
Shigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
Current surgical management for melanoma. The Journal of dermatology 51 (3) (2023)
Takashi Inozume
Adoptive cell transfer therapy for melanoma. Experimental dermatology (2022)
Toshihiro Kimura, Satoshi Fukushima, Etsuko Okada, Haruka Kuriyama, Hisashi Kanemaru, Mina Kadohisa-Tsuruta, Yosuke Kubo, Satoshi Nakahara, Aki Tokuzumi, Ikko Kajihara, Katsunari Makino, Azusa Miyashita, Jun Aoi, Takamitsu Makino, Hirotake Tsukamoto, Yasuharu Nishimura, Takashi Inozume, Rong Zhang, Yasushi Uemura, Satoru Senju, Hironobu Ihn
Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma. Pigment cell & melanoma research 33 (5) (2020)
Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki, Takashi Inozume, Kenjiro Namikawa, Ayato Hayashi, Satoshi Fukushima, Taku Fujimura, Takamichi Ito, Keisuke Imafuku, Ryota Tanaka, Yukiko Teramoto, Akane Minagawa, Takuya Miyagawa, Azusa Miyashita, Makoto Wada, Hiroshi Koga, Makoto Sugaya
Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. The Journal of dermatology 47 (2) (2019)
Kenji Yokota, Hiroshi Uchi, Hisashi Uhara, Shusuke Yoshikawa, Tatsuya Takenouchi, Takashi Inozume, Kentaro Ozawa, Hironobu Ihn, Yasuhiro Fujisawa, Anila Qureshi, Veerle de Pril, Yasushi Otsuka, Jeffrey Weber, Naoya Yamazaki
Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Japanese subgroup analysis from the phase 3 CheckMate 238 study. The Journal of dermatology 46 (12) (2019)
Takashi Inozume, Toshiyuki Tsunoda, Takashi Morisaki, Kazutoshi Harada, Seiji Shirasawa, Tatsuyoshi Kawamura
Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell line. The Journal of dermatology 45 (12) (2018)
Takashi Inozume, Ken-Ichi Hanada, Kazuyo Takeda, Tatsuo Maeda, Kazutoshi Harada, Tatsuyoshi Kawamura
Cytotoxic T-lymphocyte-associated protein 4 expressed by melanoma cells does not affect melanoma-specific cytotoxic T lymphocytes in the effector phase. The Journal of dermatology 46 (1) (2018)